PErioperAtive CHildhood ObesitY (PEACHY)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03994419|
Recruitment Status : Not yet recruiting
First Posted : June 21, 2019
Last Update Posted : June 21, 2019
The incidence of childhood obesity is at epidemic levels and increasing in the UK. Obese adults are considered a high-risk group of patients for general anaesthesia with published national guidelines on the best practice management. The proportion of children presenting for a procedure under general anaesthesia in the UK who are overweight or obese is currently unknown.
Obese children are perceived to be at greater risk of complications from general anaesthesia. Previous non-UK studies suggest they take longer to recover from anaesthesia, require more medications to combat nausea and vomiting and are at greater risk of complications that may threaten their airway and breathing.
This study involves reviewing the anaesthetic care record and patient notes to collect information relating to general anaesthesia and basic demographic data in children aged 2-16 years presenting for a procedure under general anaesthesia.
The aims of this study are to establish the prevalence of obesity in the paediatric surgical population (i.e. the proportion of children attending UK hospitals for procedures under general anaesthesia who are overweight or obese) and to ascertain whether obese children are at increased risk compared to their healthy weight counterparts.
This information will be used with the goal of reducing avoidable harm both at national and local level in the future.
|Condition or disease||Intervention/treatment|
|Pediatric Obesity Obesity, Childhood Overweight and Obesity Perioperative/Postoperative Complications||Procedure: Anaesthesia for surgery|
Show Detailed Description
|Study Type :||Observational|
|Estimated Enrollment :||8000 participants|
|Official Title:||PErioperAtive CHildhood obesitY (PEACHY): A Prospective Observational Cohort Study Investigating the Proportion of Overweight and Obese Children Presenting for a Procedure Under General Anaesthesia in the UK and the Incidence of Perioperative Adverse Outcomes in This Patient Group|
|Estimated Study Start Date :||September 9, 2019|
|Estimated Primary Completion Date :||October 6, 2019|
|Estimated Study Completion Date :||October 6, 2019|
- Procedure: Anaesthesia for surgery
Observational study observing proportion of obese and overweight children attending for surgery. Observing adverse events following general anaesthesia for surgery in obese versus healthy weight children.
- Proportion of overweight and obesity in UK children attending for surgery [ Time Frame: One week study period ]The proportion of overweight and obesity in UK children aged 2-16 years attending hospitals for a procedure under general anaesthesia.
- Adverse events [ Time Frame: One week study period ]The proportion of defined adverse events occurring in obese children as compared to healthy weight children attending for a procedure under general anaesthesia.
- Paracetamol dosing variation [ Time Frame: One week study period ]The variation in paracetamol dosing in obese children in the UK perioperative setting.
- Surgery types [ Time Frame: One week study period ]The proportion of obese children presenting for certain types of surgery compared to their healthy weight counterparts.
- Comparison with the UK National Child Measurement Programme [ Time Frame: One week study period ]The difference in the proportion of overweight and obesity in the perioperative setting compared to that from the UK National Child Measurement Programme (NCMP).
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03994419
|Contact: Zoe A Burton, MBBCh||00447921865041||UHS.PEACHY@nhs.net|
|Contact: Rachael Meering||00442381205044||Rachael.email@example.com|
|Principal Investigator:||Mark Edwards||University Hospital Southampton NHS Trust|